58 related articles for article (PubMed ID: 10487567)
1. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).
Carrie C; Hoffstetter S; Gomez F; Moncho V; Doz F; Alapetite C; Murraciole X; Maire JP; Benhassel M; Chapet S; Quetin P; Kolodie H; Lagrange JL; Cuillere JC; Habrand JL
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):435-9. PubMed ID: 10487567
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Simultaneous Temporal Relapses of Medulloblastoma.
Martinez-Moreno M; Galván de la Cruz OO; Flores-Balcázar CH; Rosales-Pérez S; Rembao-Bojórquez D; Moreno-Jiménez S
Cureus; 2018 Feb; 10(2):e2170. PubMed ID: 29644158
[TBL] [Abstract][Full Text] [Related]
3. Validation of an automated contouring and treatment planning tool for pediatric craniospinal radiation therapy.
Hernandez S; Burger H; Nguyen C; Paulino AC; Lucas JT; Faught AM; Duryea J; Netherton T; Rhee DJ; Cardenas C; Howell R; Fuentes D; Pollard-Larkin J; Court L; Parkes J
Front Oncol; 2023; 13():1221792. PubMed ID: 37810961
[TBL] [Abstract][Full Text] [Related]
4. Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review.
Osuna-Marco MP; Martín-López LI; Tejera ÁM; López-Ibor B
Front Oncol; 2023; 13():1229853. PubMed ID: 37456257
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of sub-frontal recurrent medulloblastomas reveals potential clinical relevance.
Chen Z; Yang H; Wang J; Long G; Xi Q; Chen T; He Y; Zhang B; Wan F
Front Neurol; 2023; 14():1148848. PubMed ID: 37181548
[TBL] [Abstract][Full Text] [Related]
6. An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
Schiff JP; Lee Y; Wang Y; Perkins SM; Kessel SK; Fitzgerald TJ; Larrier NA; Michalski JM
Adv Radiat Oncol; 2023; 8(1):101083. PubMed ID: 36483060
[TBL] [Abstract][Full Text] [Related]
7. The relapse doesn't fall far from the radiotherapy field: Lessons to be learned for the future of radiotherapy in medulloblastoma from the relapse patterns of SJMB03.
Saran F; Eisenstat DD
Neuro Oncol; 2022 Jul; 24(7):1176-1177. PubMed ID: 35325220
[No Abstract] [Full Text] [Related]
8. SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma.
Mynarek M; Milde T; Padovani L; Janssens GO; Kwiecien R; Mosseri V; Clifford SC; Doz F; Rutkowski S
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885186
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.
Seidel C; Heider S; Hau P; Glasow A; Dietzsch S; Kortmann RD
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885055
[TBL] [Abstract][Full Text] [Related]
10. Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Weber DC; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Obrecht D; Rutkowski S; Timmermann B; Kortmann RD
Strahlenther Onkol; 2022 Mar; 198(3):282-290. PubMed ID: 34351451
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance in radiation oncology.
FitzGerald TJ; Followill D; Laurie F; Boterberg T; Hanusik R; Kessel S; Karolczuk K; Iandoli M; Ulin K; Morano K; Bishop-Jodoin M; Kry S; Lowenstein J; Molineu A; Moni J; Cicchetti MG; Prior F; Saltz J; Sharma A; Mandeville HC; Bernier-Chastagner V; Janssens G
Pediatr Blood Cancer; 2021 May; 68 Suppl 2(Suppl 2):e28609. PubMed ID: 33818891
[TBL] [Abstract][Full Text] [Related]
12. Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise.
Mul J; Melchior P; Seravalli E; Saunders D; Bolle S; Cameron AL; Gurtner K; Harrabi S; Lassen-Ramshad Y; Lavan N; Magelssen H; Mandeville H; Boterberg T; Kroon PS; Kotte ANTJ; Hoeben BAW; van Rossum PSN; van Grotel M; Graf N; van den Heuvel-Eibrink MM; Rübe C; Janssens GO
Clin Transl Radiat Oncol; 2021 May; 28():39-47. PubMed ID: 33796796
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Walser M; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Rutkowski S; Timmermann B; Kortmann RD
Strahlenther Onkol; 2021 Aug; 197(8):674-682. PubMed ID: 33226469
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Models of Craniospinal Irradiation for Medulloblastoma.
Stripay JL; Merchant TE; Roussel MF; Tinkle CL
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31948065
[No Abstract] [Full Text] [Related]
15. A dedicated cloud system for real-time upfront quality assurance in pediatric radiation therapy.
Meroni S; Cavatorta C; Barra S; Cavagnetto F; Scarzello G; Scaggion A; Pecori E; Diletto B; Alessandro O; Massimino M; Gianolini S; Pignoli E; Gandola L
Strahlenther Onkol; 2019 Sep; 195(9):843-850. PubMed ID: 31025053
[TBL] [Abstract][Full Text] [Related]
16. Differences in Parotid Dosimetry and Expected Normal Tissue Complication Probabilities in Whole Brain Radiation Plans Covering C1 Versus C2.
Orton A; Gordon J; Vigh T; Tonkin A; Cannon G
Cureus; 2017 May; 9(5):e1217. PubMed ID: 28589066
[TBL] [Abstract][Full Text] [Related]
17. Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.
Noble DJ; Ajithkumar T; Lambert J; Gleeson I; Williams MV; Jefferies SJ
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):439-447. PubMed ID: 28318880
[TBL] [Abstract][Full Text] [Related]
18. Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves.
Noble DJ; Scoffings D; Ajithkumar T; Williams MV; Jefferies SJ
Br J Radiol; 2016 Nov; 89(1067):20160392. PubMed ID: 27636022
[TBL] [Abstract][Full Text] [Related]
19. Automated Extraction of Dose/Volume Statistics for Radiotherapy-Treatment-Plan Evaluation in Clinical-Trial Quality Assurance.
Gong YU; Yu J; Pang D; Zhen H; Galvin J; Xiao Y
Front Oncol; 2016; 6():47. PubMed ID: 26973814
[TBL] [Abstract][Full Text] [Related]
20. Prospective study on dosimetric comparison of helical tomotherapy and 3DCRT for craniospinal irradiation - A single institution experience.
Bandurska-Luque A; Piotrowski T; Skrobała A; Ryczkowski A; Adamska K; Kaźmierska J
Rep Pract Oncol Radiother; 2015; 20(2):145-52. PubMed ID: 25859405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
